Register Now: IKRIS Breast Cancer Awareness Run 2022

Search results for:lenalidomide

NICE recommends a triplet therapy comprised of Kyprolis, lenalidomide and dexamethasone for MM

The NICE has specifically recommended a triplet therapy comprised of Kyprolis (carfilzomib), lenalidomide and dexamethasone in order to treat previously […]

March 23, 2021


WHAT IS LENALIDOMIDE AND WHAT IT IS USED FOR: Lenalidomide is a thalidomide analogue indicated for the treatment of: Multiple […]

October 27, 2020

Cipla Gets the Final Approval for Generic Version of Revlimid by US FDA

On September 7’th, 2022, Cipla Ltd announced that it has received final approval for its generic version (ANDA) of Lenalidomide […]

September 12, 2022

Multiple Myeloma: Treatment and Medications

Being the second most common type of blood cancer, 5-6% of the world population is diagnosed with Multiple Myeloma every […]

December 8, 2020

Carfilzomib: Anti-cancer medication

Carfilzomib is an anti-cancer drug sold under the trade name Kyprolis. It acts as a selective proteasome inhibitor(drugs that block […]

September 9, 2021


WHAT IS CARFILZOMIB AND WHAT IT IS USED FOR? Carfilzomib¬†is an anti-cancer drug indicated to use as a selective proteasome […]

December 2, 2020

Ikris Pharmaceutical in Brazil Health sector

We, Ikris Pharma Network are International pharmaceutical distributors from India. We supply products to all the people involved in the […]

October 20, 2021


WHAT IS POMALIDOMIDE AND WHAT IT IS USED FOR: Pomalidomide is an anti-angiogenic medication indicated for the treatment of: Relapsed […]

December 4, 2020